| scholarly article | Q13442814 |
| P50 | author | Kate Rittenhouse-Olson | Q51125775 |
| P2093 | author name string | Munawwar Sajjad | |
| Arti Yadav | |||
| Julia Abdullah | |||
| Susan Morey | |||
| Jing Ying Eng | |||
| Stephen Koury | |||
| Gabriel Hrysenko | |||
| Kimiko Ferguson | |||
| P2860 | cites work | PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro | Q21195212 |
| A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes | Q24647928 | ||
| Systematic variation in gene expression patterns in human cancer cell lines | Q28145747 | ||
| Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths | Q28241157 | ||
| Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery | Q33479152 | ||
| In vivo tumor cell adhesion in the pulmonary microvasculature is exclusively mediated by tumor cell--endothelial cell interaction | Q33569192 | ||
| Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer | Q33732173 | ||
| Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer. | Q34500864 | ||
| Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs | Q34768486 | ||
| Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11 | Q35249810 | ||
| Tumor immunolocalization using 124 I-iodine-labeled JAA-F11 antibody to Thomsen-Friedenreich alpha-linked antigen | Q35334908 | ||
| Jaa-f11: extending the life of mice with breast cancer | Q36897363 | ||
| Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene | Q37684502 | ||
| Management of triple negative breast cancer | Q37728718 | ||
| Bevacizumab for the first-line treatment of human epidermal growth factor receptor 2-negative advanced breast cancer | Q37864901 | ||
| Human carcinoma-associated precursor antigens of the NM blood group system | Q37951984 | ||
| Anti-Thomsen-Friedenreich-Ag (anti-TF-Ag) potential for cancer therapy. | Q37971784 | ||
| Correlative fine specificity of several Thomsen-Friedenreich disaccharide-binding proteins with an effect on tumor cell proliferation | Q38299375 | ||
| Development and characterization of monoclonal antibody to T-antigen: (gal beta1-3GalNAc-alpha-O). | Q38336624 | ||
| T-antigen in normal and neoplastic urothelium | Q38350477 | ||
| Blood group MN precursors as human breast carcinoma-associated antigens and "naturally" occurring human cytotoxins against them | Q39365869 | ||
| MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? | Q39834203 | ||
| A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists | Q40748497 | ||
| Adhesion or anti-adhesion in cancer: what matters more? | Q41121051 | ||
| Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy | Q41594089 | ||
| Comment Re: MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma? | Q57652970 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | monoclonal antibody | Q422248 |
| P304 | page(s) | 385-399 | |
| P577 | publication date | 2014-02-01 | |
| P1433 | published in | Future Oncology | Q2781597 |
| P1476 | title | Preclinical studies with JAA-F11 anti-Thomsen-Friedenreich monoclonal antibody for human breast cancer | |
| P478 | volume | 10 |
| Q64117571 | A conserved major facilitator superfamily member orchestrates a subset of O-glycosylation to aid macrophage tissue invasion |
| Q64091306 | CD1d highly expressed on DCs reduces lung tumor burden by enhancing antitumor immunity |
| Q26746887 | Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses |
| Q41478234 | Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis |
| Q39935587 | Immunological evaluation of the entirely carbohydrate-based Thomsen-Friedenreich - PS B conjugate |
| Q49901112 | Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1. |
| Q52686871 | Preclinical Analysis of JAA-F11, a Specific Anti-Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging. |
| Q91844287 | Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential |
| Q38966611 | Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen |
| Q38900869 | p53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer |
Search more.